EUVIMEDEUVIMED entdecken
Crossref

L26/P-622 Biopsy Difficulty Index and Genetic outcome in Pre Implantation Genetic Testing for Aneuploidy cycles

S. Herle

Human Reproduction · 01.07.2026 · 41 (Supplement_1)

DOI: 10.1093/humrep/deag083.952 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von S. Herle.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Study question Does the technical difficulty of Trophectoderm biopsy influence genetic outcomes in PGT-A cycles? Summary answer A higher Biopsy Difficulty Index (BDI) is associated with adverse genetic outcomes, including reduced euploidy rates and increased non-euploid and chaotic results in PGT-A embryos. What is known already Trophectoderm biopsy is a critical step in PGT-A, yet it remains operator-dependent. While biopsy technique is known to influence cell yield and embryo handling, the relationship between biopsy difficulty and downstream genetic outcomes has not been systematically quantified. Study design, size, duration This was a retrospective observational study conducted at a single IVF center in 2025, analyzing 100 blastocysts undergoing Pre Implantation Genetic Testing for Aneuploidy (PGT-A). Participants/materials, setting, methods Blastocysts undergoing trophectoderm biopsy and PGT-A via NGS were analyzed. A Biopsy Difficulty Index (BDI) was created using four parameters: number of laser shots, biopsy duration, trophectoderm stretch (assessed by visible elongation), and cells retrieved, each scored 0–2. Embryos were categorized as easy (0–2), moderate (3–5), or difficult (6–8). Genetic outcomes—euploid, aneuploid, mosaic, or chaotic—were compared across BDI groups using the chi-square test. Main results and the role of chance Embryos with high BDI scores demonstrated a lower proportion of euploid results and a higher incidence of aneuploid, mosaic, and chaotic outcomes compared with embryos in the low and moderate BDI groups. Euploidy rates decreased progressively from the easy to difficult BDI groups. Difficult biopsies were also associated with reduced cell yield. The observed associations were statistically significant (p < 0.05). Limitations, reasons for caution The study is limited by its retrospective design, single-center setting, and moderate sample size. Operator experience and embryo intrinsic factors may act as confounders. Wider implications of the findings The Biopsy Difficulty Index offers a practical and reproducible tool to objectively assess biopsy complexity. Incorporating BDI into routine laboratory practice may help embryologists anticipate genetic reliability, optimize biopsy strategy, and improve counseling in PGT-A cycles. BDI may also serve as a quality assurance and training metric within IVF laboratories. Trial registration number No

Zitieren

APA

Herle, S. (2026). L26/P-622 Biopsy Difficulty Index and Genetic outcome in Pre Implantation Genetic Testing for Aneuploidy cycles. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.952

Vancouver

Herle S. L26/P-622 Biopsy Difficulty Index and Genetic outcome in Pre Implantation Genetic Testing for Aneuploidy cycles. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.952

BibTeX
@article{Herle2026,
  author = {Herle, S.},
  title = {L26/P-622 Biopsy Difficulty Index and Genetic outcome in Pre Implantation Genetic Testing for Aneuploidy cycles},
  journal = {Human Reproduction},
  year = {2026},
  volume = {41},
  number = {Supplement_1},
  doi = {10.1093/humrep/deag083.952}
}
Kostenlos starten →